Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 170-177 , June 2009

Cortisol controlled release by mesoporous silica

  • Tessy Lopez, PhD

      Affiliations

    • Departamento Atención a la Salud, Universidad Autónoma Metropolitana-Xochimilco, Tlalpan, México DF, México
    • Instituto Nacional de Neurología y Neurocirugía “MVS”, México DF, México
    • Corresponding Author InformationCorresponding author. National Institute of Neurology and Neurosurgery, Nanotechnology, Parque Palacio 2, Colonia El Parque de Coyoacan Del., México D.F., México 04899, Mexico.
    • ,
  • Emma Ortiz, PhD

      Affiliations

    • Instituto Nacional de Neurología y Neurocirugía “MVS”, México DF, México
    • ,
  • Roberto Alexander-Katz, PhD

      Affiliations

    • Departamento de Física, Universidad Autónoma Metropolitana-Iztapalapa, México DF, México
    • ,
  • Elena Basaldella, PhD

      Affiliations

    • CIC-CINDECA–Universidad Nacional de La Plata, La Plata, Argentina
    • ,
  • Xim Bokhimi, PhD

      Affiliations

    • Instituto de Física de la Universidad Nacional Autónoma de México, Circuito de la Investigación s/n, Ciudad Universitaria, México DF, México

Received 17 December 2007 ,Accepted 14 August 2008.

References 

  1. Benoit J-P, Faisant N, Verniere-Julienne M-C, Menei P. Developments of microspheres for neurological disorders: from basics to clinical applications. J Control Release. 2000;65:285–296
  2. Siepmann J, Faisant N, Akiki J, Richard J, Benoit JP. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release. 2004;96:123–134
  3. Tatard VM, Venier-Julienne MC, Saulnier P, Prechter E, Benoit JP, Menei P, et al. Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials. 2005;26:3727–3737
  4. Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm. 2006;314:127–136
  5. Koennings S, Garcion E, Faisant N, Menei P, Benoit JP, Goepferich A. In vitro investigation of lipid implants as a controlled release system for interleukin-18. Int J Pharm. 2006;314:145–152
  6. Olivier J-C. Drug transport to brain with targeted nanoparticle. NeuroRX. 2005;2:108–119
  7. Mannila A, Rautio J, Lehtonen M, Järvinen T, Savolainen J. Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases. Eur J Pharm Sci. 2005;24:101–105
  8. Shaffer C. Nanomedicine transforms drug delivery. Drug Discov Today. 2005;10:1581–1582
  9. Popovic N, Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm. 2006;314:120–126
  10. Calabria AR, Shusta EV. Blood–brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov Today. 2006;11:792–799
  11. Rösler A, Vandermeulen GWM, Klok H-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev. 2001;53:95–108
  12. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92:1343–1355
  13. López T, Ortiz E, Quintana P, González RD. Nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain. Colloids Surf A Physicochem Eng Aspects. 2007;300:3–10
  14. Lopez T, Quintana P, Ascencio J, Gonzalez RD. The determination of dielectric constants of mixtures used in the treatment of epilepsy and the encapsulation of phenytoin in a titania matrix. Colloids Surf A Physicochem Eng Aspects. 2007;300:99–105
  15. Lopez T, Ortiz-Islas E, Manjarrez J, Rodriguez Reinoso F, Sepulveda A, Gonzalez RD. Biocompatible titania microtubes formed by nanoparticles and its application in the drug delivery of valproic acid. Optical Mater. 2006;29:70–74
  16. Lopez T, Manjares J, Rembao D, Vinogradova E, Moreno A, Gonzalez RD. An implantable sol-gel derived titania-silica carrier system for the controlled release of anticonvulsants. Mater Lett. 2006;60:2903–2908
  17. Lopez T, Quintana P, Ortiz-Islas E, Vinogradova E, Manjarrez J, Aguilar DH, et al. Characterization of sodium phenytoin cogelled with titania to be used as controlled drug release system. Mater Charact. 2007;58:823–828
  18. López T, Basaldella EI, Ojeda ML, Manjarrez J, Alexander-Katz R. Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy. Optical Mater. 2006;29:75–81
  19. López T, Sotelo J, Navarrete J, Ascencio JA. Synthesis of TiO2 nanostructured reservoir with temozolomide: structural evolution of the occluded drug. Optical Mater. 2006;29:88–94
  20. López T, Recillas S, Guevara P, Sotelo J, Alvarez M, Odriozola JA. Pt/TiO2 brain biocompatible nanoparticles: GBM treatment using C6 model in Wistar rats. Acta Biomater. 2008;[in press] (available online)
  21. Lopez T, Krotsch E, Ortiz-Islas E, Alvarez M, Basaldella E, Blanes JM, et al. Release properties and acute biosecurity determination of collagen-polyvinylpyrrolidone loaded in ordered mesoporous silica. Key Eng Materials. 2009;391:169–184(Available online at www.scientific.net
  22. Vallet-Regi M, Rámila A, del Real RP, Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater. 2001;13:308–311
  23. Doadrio AL, Sousa EMB, Doadrio JC, Pérez-Pariente J, Izquierdo-Barba I, Vallet-Regi M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release. 2004;97:125–132
  24. Tamargo RJ, Leong KW, Brem H. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J Neuro-Oncol. 1990;9:131–138
  25. Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Chmelka BF, et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science. 1998;279:548–552
  26. Floström K, Alfredsson V, Källrot N. Formation of a new Ia3d cubic meso-structured silica via triblock copolymer-assisted synthesis. J Am Chem Soc. 2003;125:4402–4403
  27. Janicke MT, Landry CC, Christiansen SC, Britalan S, Stucky GD, Chmelka BF. Low silica MCM-41 composites and mesoporous solids. Chem Mater. 1999;11:1342–1351
  28. van Grieken R, Calleja G, Stucky GD, Melero JA, García RA, Iglesias J. Supercritical fluid extraction of a nonionic surfactant template from SBA-15 materials and consequences on the porous structure. Langmuir. 2003;19:3966–3973
  29. Leontidis E. Hofmeister anion effects on surfactant self-assembly and the formation of mesoporous solids. Curr Opin Colloid Interface Sci. 2002;7:81–91
  30. Bagshaw SA. The effect of dilute electrolytes on the formation of non-ionically templated [Si]-MSU-X mesoporous silica molecular sieves. J Mater Chem. 2001;11:831–840

 Sources of support for this research: Universidad Autonoma Metropolitana (México), Instituto Nacional de Neurología y Neurocirugía “MVS” (México), and CYTED program (Spain).

PII: S1549-9634(08)00145-7

doi: 10.1016/j.nano.2008.08.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 170-177 , June 2009

Article Tools

* Image Usage & Resolution